388 related articles for article (PubMed ID: 8467387)
1. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.
Rassnick S; Heinrichs SC; Britton KT; Koob GF
Brain Res; 1993 Mar; 605(1):25-32. PubMed ID: 8467387
[TBL] [Abstract][Full Text] [Related]
2. CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.
Baldwin HA; Rassnick S; Rivier J; Koob GF; Britton KT
Psychopharmacology (Berl); 1991; 103(2):227-32. PubMed ID: 2027923
[TBL] [Abstract][Full Text] [Related]
3. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
Valdez GR; Roberts AJ; Chan K; Davis H; Brennan M; Zorrilla EP; Koob GF
Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence.
Valdez GR; Zorrilla EP; Roberts AJ; Koob GF
Alcohol; 2003 Feb; 29(2):55-60. PubMed ID: 12782246
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
Huang MM; Overstreet DH; Knapp DJ; Angel R; Wills TA; Navarro M; Rivier J; Vale W; Breese GR
J Pharmacol Exp Ther; 2010 Jan; 332(1):298-307. PubMed ID: 19843974
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats.
Funk CK; O'Dell LE; Crawford EF; Koob GF
J Neurosci; 2006 Nov; 26(44):11324-32. PubMed ID: 17079660
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats.
Basso AM; Spina M; Rivier J; Vale W; Koob GF
Psychopharmacology (Berl); 1999 Jul; 145(1):21-30. PubMed ID: 10445369
[TBL] [Abstract][Full Text] [Related]
8. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors.
Overstreet DH; Knapp DJ; Breese GR
Pharmacol Biochem Behav; 2004 Feb; 77(2):405-13. PubMed ID: 14751471
[TBL] [Abstract][Full Text] [Related]
9. Interactions of stress and CRF in ethanol-withdrawal induced anxiety in adolescent and adult rats.
Wills TA; Knapp DJ; Overstreet DH; Breese GR
Alcohol Clin Exp Res; 2010 Sep; 34(9):1603-12. PubMed ID: 20586753
[TBL] [Abstract][Full Text] [Related]
10. Amygdaloid corticotropin-releasing factor is involved in the anxiolytic effect of acupuncture during ethanol withdrawal in rats.
Zhao Z; Jin X; Wu Y; Yang X; Xu Y; Jiang JZ; Kim SC; Lee BH; Yang CH; Zhao R
J Acupunct Meridian Stud; 2013 Oct; 6(5):234-40. PubMed ID: 24139460
[TBL] [Abstract][Full Text] [Related]
11. Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation.
Valdez GR; Sabino V; Koob GF
Alcohol Clin Exp Res; 2004 Jun; 28(6):865-72. PubMed ID: 15201629
[TBL] [Abstract][Full Text] [Related]
12. Methanol extract of semen Ziziphi Spinosae attenuates ethanol withdrawal anxiety by improving neuropeptide signaling in the central amygdala.
Li LB; Kim YW; Wang YH; Bai L; Zhu XD; Zhao ZL; Lee CW; Jiao Y; Wu T; Cai ZZ; Kim SC; An WG; Yang CH; Cui GC; Zhao RJ
BMC Complement Altern Med; 2019 Jun; 19(1):147. PubMed ID: 31234859
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.
Heinrichs SC; Pich EM; Miczek KA; Britton KT; Koob GF
Brain Res; 1992 May; 581(2):190-7. PubMed ID: 1327398
[TBL] [Abstract][Full Text] [Related]
14. Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal.
McNally GP; Akil H
Neuroscience; 2002; 112(3):605-17. PubMed ID: 12074902
[TBL] [Abstract][Full Text] [Related]
15. Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala.
Sajdyk TJ; Gehlert DR
Brain Res; 2000 Sep; 877(2):226-34. PubMed ID: 10986336
[TBL] [Abstract][Full Text] [Related]
16. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats.
Sarnyai Z; Bíró E; Gardi J; Vecsernyés M; Julesz J; Telegdy G
Brain Res; 1995 Mar; 675(1-2):89-97. PubMed ID: 7796157
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.
Britton KT; Akwa Y; Spina MG; Koob GF
Peptides; 2000 Jan; 21(1):37-44. PubMed ID: 10704717
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
[TBL] [Abstract][Full Text] [Related]
19. CRF receptor type 1 (but not type 2) located within the amygdala plays a role in the modulation of anxiety in mice exposed to the elevated plus maze.
Cipriano AC; Gomes KS; Nunes-de-Souza RL
Horm Behav; 2016 May; 81():59-67. PubMed ID: 27060334
[TBL] [Abstract][Full Text] [Related]
20. A role for corticotropin-releasing factor in repeated cold stress-induced anxiety-like behavior during forced swimming and elevated plus-maze tests in mice.
Nishikawa H; Hata T; Itoh E; Funakami Y
Biol Pharm Bull; 2004 Mar; 27(3):352-6. PubMed ID: 14993801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
